Hadasit Bio Holding Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
IL0010954050
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.43M 2M 743M 2.73M |
---|---|---|---|---|---|
Net income 2022 | -31M -8.35M -3.1B -11.4M | Net income 2023 | -29M -7.81M -2.9B -10.66M | EV / Sales 2022 | - |
Net cash position 2022 | 12.93M 3.48M 1.29B 4.75M | Net cash position 2023 | 6.46M 1.74M 646M 2.38M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.46
x | P/E ratio 2023 |
-0.25
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25% |
Managers | Title | Age | Since |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 15-09-19 |
Tamar Raz
CHM | Chairman | 60 | 14-05-17 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 15-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 18-07-28 |
Erez Meltzer
BRD | Director/Board Member | 66 | 16-07-04 |
Orit Stav
BRD | Director/Board Member | 53 | 17-10-31 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+45.09% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |